Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 1334Neoplasms 1111Carcinoma, Non-Small-Cell Lung 923Prostatic Neoplasms 755Colorectal Neoplasms 653Lung Neoplasms 626Neoplasm Metastasis 476Multiple Myeloma 449Leukemia, Myeloid, Acute 441Pancreatic Neoplasms 394Ovarian Neoplasms 390Melanoma 350Carcinoma, Hepatocellular 311Brain Neoplasms 293Recurrence 289Squamous Cell Carcinoma of Head and Neck 287Glioblastoma 263Head and Neck Neoplasms 256Stomach Neoplasms 255Precursor Cell Lymphoblastic Leukemia-Lymphoma 242Carcinoma, Renal Cell 241Lymphoma 237Triple Negative Breast Neoplasms 234Endometrial Neoplasms 223Hematologic Neoplasms 220Uterine Cervical Neoplasms 217Urinary Bladder Neoplasms 213Glioma 208Lymphoma, Non-Hodgkin 206Sarcoma 204

Interventions

Positron Emission Tomography Computed Tomography 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Liver Metastases × 90 days × Clear all
NCT04143516 2026-03-19

Tissue Analysis After Tumor Ablation for Liver Metastases Leading to Immediate Retreatment

Memorial Sloan Kettering Cancer Center

Phase 2/3 Recruiting
200 enrolled

Liver Metastases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡